Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrogenation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106748966B reveals a cost-effective route for high-purity pharmaceutical intermediates. Enhance supply chain reliability with scalable manufacturing solutions.
Patent CN110483420B details a novel Rh-catalyzed reduction of quinoxalines using water as a hydrogen source, offering significant cost reduction and safer manufacturing for pharmaceutical intermediates.
Patent CN105111208B enables efficient asymmetric hydrogenation. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101863954A details a high-yield 6-step route for N-tert-butyl-4-aza-5 alpha-androstane-3-ketone-17 beta-formamide, offering cost reduction in API manufacturing.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113636968B details a Ru-catalyzed route to 3-acylpyrroles. Offers cost reduction in API manufacturing and high atom economy for pharma intermediates.
Novel water-based hydrogenation method reduces costs and simplifies purification for high-purity tetrahydroquinoxaline pharmaceutical intermediates.
Patent CN113999207B reveals efficient synthesis of pyridyl-containing chiral NNN ligands via asymmetric hydrogenation, offering cost-effective routes for pharmaceutical intermediates.
Patent CN103539730A reveals scalable routes for Dabigatran intermediates using metal reduction or amine-promoted hydrogenation, ensuring supply continuity.
Novel synthesis route for 7-(trifluoromethyl) isoquinoline-5-amine. High purity pharmaceutical intermediate with scalable process and cost advantages for global supply chains.
Patent CN112358379A reveals a high-efficiency asymmetric hydrogenation route for S-1,1-bis(4-fluorophenyl)propan-2-ol, offering superior purity and scalability for florypicoxamid production.
Patent CN109824601B details an iridium-catalyzed asymmetric hydrogenation method for synthesizing chiral cyclic ureas with high enantioselectivity, offering significant supply chain advantages.
Patent CN114436831A reveals a high-yield rhodium-catalyzed asymmetric hydrogenation route for chiral esters, offering significant cost reduction in pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN113636968B details a Ru-catalyzed transfer hydrogenation route for 3-acylpyrroles, offering high atom economy and simplified purification for API intermediates.
Patent CN102256981A details a novel route for Anagrelide avoiding toxic nitriles and tin waste, offering cost reduction in pharmaceutical manufacturing and high-purity intermediates.
Breakthrough palladium-catalyzed dehydrogenation coupling method enables high-yield enamide production with mild conditions, enhancing supply chain reliability for pharmaceutical intermediates.
Novel palladium-catalyzed method enables high-yield trans-isopentenyl indole synthesis under mild conditions, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel asymmetric hydrogenation method enables high-purity dihydro-9-phenanthrene amine production with enhanced supply chain reliability and cost efficiency for pharmaceutical manufacturing.
Patent CN106187741A enables mild production of high-purity iodinated benzenetricarboxylic acid with enhanced safety and reliable supply chain for pharmaceutical intermediates.
This patent introduces a novel palladium-catalyzed method for trans-isopentenyl indole synthesis with mild conditions and high atom economy enabling significant cost reduction and reliable supply chain for pharmaceutical intermediates manufacturing